|
| Title |
|
|
|
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Nature communications | |
| Publication |
|
|
|
2018
| |
| ISSN |
|
|
|
2041-1723
| |
| Volume/pages |
|
|
|
9(2018), 16 p.
| |
| Article Reference |
|
|
|
4112
| |
| ISI |
|
|
|
000446496100003
| |
| Pubmed ID |
|
|
|
30291241
| |
| Medium |
|
|
|
E-only publicatie
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|
| Faculty/Department |
|
|
| | |
| Research group |
|
|
|
| Project info |
|
|
|
ANGIOPREDICT: Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer
| Publication type |
|
|
| | | |
| Subject |
|
|
| | | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
09.11.2018
|
|
| Last edited |
|
| |
24.06.2020
|
|
| To cite this reference |
|
|
| | |
|
| |